Clinical Trials at HonorHealth Research Institute
As of September 2026, 22 paid clinical trials are recruiting at HonorHealth Research Institute, located at 7285 E EARLL DR, SCOTTSDALE, AZ 85251-7230, phone (480) 949-1909 in Scottsdale, Arizona. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Advanced Solid Tumor and Hematopoietic and Lymphatic System Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
22 clinical trials at HonorHealth Research Institute
·Clear filters·Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
A Study of PYX-201 in Advanced Solid Tumors
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
SW-682 in Advanced Solid Tumors
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Common conditions studied in Scottsdale
- Malignant Solid Neoplasm (12 active studies)
- Advanced Solid Tumor (9 active studies)
- Cancer (9 active studies)
- Hematopoietic and Lymphatic System Neoplasm (9 active studies)
- Breast Cancer (8 active studies)
- Solid Tumor (8 active studies)
Leading research sponsors in Scottsdale
- Mayo Clinic
- Eli Lilly and Company
- Pfizer
- Sanofi
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Scottsdale?
There are approximately 393 recruiting clinical trials in Scottsdale, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scottsdale pay participants?
Most recruiting trials in Scottsdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scottsdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scottsdale?
The most common conditions under active study in Scottsdale include Malignant Solid Neoplasm (12), Advanced Solid Tumor (9), Cancer (9), Hematopoietic and Lymphatic System Neoplasm (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scottsdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scottsdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scottsdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scottsdale?
Recruiting research sites in Scottsdale include Mayo Clinic in Arizona, Mayo Clinic Arizona, HonorHealth Research Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scottsdale right now?
The largest active categories in Scottsdale are Cancer & tumors (129), Neurology & pain (26), Cardiovascular (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of HonorHealth Research Institute?
HonorHealth Research Institute is located at 7285 E EARLL DR, SCOTTSDALE, AZ 85251-7230. Use the Google Maps link in the intro above to get directions.
How do I contact HonorHealth Research Institute?
You can reach HonorHealth Research Institute by phone at (480) 949-1909. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.